top of page
ARTICULATE BIOSCIENCES AWARDED $225,000 PHASE I SBIR GRANT FROM NATIONAL SCIENCE FOUNDATION
June 2018
The grant will be utilized to further develop the ABX Technology in the company's family of injectable gels, ABX Viscoelastics. The project involves gel formulation and sterilization studies, as well as further biocompatibility testing.
Grants: News
ARTICULATE BIOSCIENCES AWARDED $200,000 PHASE I SBIR GRANT FROM NATIONAL INSTITUTES OF HEALTH
September 2017
The grant will be used to develop Articulate's ABX Technology for treating osteoarthritis. The company will investigate modes of cartilage protection, cell and tissue biocompatibility, and manufacturing scalability of ABX polymers.
Grants: News
bottom of page